Business
Sernova to Present at Virtual BIO Investor Forum
(TheNewswire) Sernova to deliver corporate update with focus on v...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova to Present at Virtual BIO Investor Forum\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Sernova to deliver\ncorporate update with focus on value-driving events:\n \n technology acquisition, licensing and research collaboration\n \n \n \n \n \n \n LONDON, ONTARIO -\n \n \n TheNewswire -\n \n \n September 24, 2020 - Sernova Corp. (TSXV:SVA)\n(OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company,\nannounced today that Dr. Philip Toleikis, President and CEO, will\nprovide a corporate update as part of the Company Presentations at the\nupcoming BIO Investor Forum Digital international biotech investor\nconference from October 13-15, 2000. Dr. Toleikis will also be engaged\nwith the BIO One-on-One Partnering meetings.\n \n \n \n \n \"Amidst the COVID-19 pandemic, we are leveraging\nthe proliferation of the virtual conference format. This virtual\nconference will enable us to increase the awareness level amongst an\nexpanded base of potential investors and partnering prospects about\nSernova's significant advancements, including first-time diabetes\nclinical trial findings, a technology acquisition for our cell therapy\ntherapeutics platform, and local immune protection technology\nlicensing and research collaboration arrangements. The BIO One-on-One\nPartnering meeting sessions will also enable us to continue\ndiscussions and further evaluate opportunities,\" said Dr. Philip\nToleikis, President and CEO of Sernova.\n \n \n \n \n Sernova's presentation will be available on-demand to\nattendees of the BIO Investor Forum Digital conference. For more\ndetails on Sernova's presentation, please visit\n \n \n \n \n https://www.bio.org/events/bio-investor-forum-digital/company-presentations\n \n \n \n \n .\n \n \n \n \n ABOUT SERNOVA CORP.\n \n \n \n \n Sernova Corp is developing regenerative medicine\ntherapeutic solutions using a medical device (Cell Pouch(TM)) and\nimmune protected therapeutic cells/tissues (i.e. human donor cells,\ncorrected human cells, and stem cell-derived cells) to improve the\ntreatment and quality of life of people with chronic metabolic\ndiseases such as insulin-dependent diabetes, blood disorders including\nhemophilia, and other diseases treated through cellular production of\nproteins or hormones missing or in short supply within the body. For\nmore information,...